Neoral is superior to FK 506 in liver transplantation
- 1 August 1998
- journal article
- review article
- Published by Elsevier in Transplantation Proceedings
- Vol. 30 (5) , 1812-1815
- https://doi.org/10.1016/s0041-1345(98)00442-4
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Neoral in de novo liver transplantation: Adequate immunosuppression without intravenous cyclosporineLiver Transplantation and Surgery, 1997
- Prednisone Withdrawal Late After Adult Liver Transplantation Reduces Diabetes, Hypertension, and Hypercholesterolemia Without Causing Graft LossHepatology, 1997
- Pharmacokinetics of a New Oral Formulation of Cyclosporine in Liver Transplant RecipientsTherapeutic Drug Monitoring, 1995
- A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver TransplantationNew England Journal of Medicine, 1994
- Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejectionThe Lancet, 1994
- VARIABLE EFFECTS OF STEROID WITHDRAWAL ON BLOOD PRESSURE REDUCTION IN CYCLOSPORINE-TREATED RENAL TRANSPLANT RECIPIENTSTransplantation, 1992
- Intraindividual variability in the relative systemic availability of cyclosporin after oral dosingEuropean Journal of Clinical Pharmacology, 1988